Clinical trial
ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head…
NCT00006106 · National Cancer Institute (NCI), NIH · Withdrawn
Key facts
| NCT number | NCT00006106 |
|---|---|
| Title | ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer |
| Official title | Phase I Study of Intraarterial ONYX-015 in Combination With Intravenous Cisplatin and Fluorouracil in Patients With Advanced Squamous Cell Cancer of the Head and Neck |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Dana-Farber Cancer Institute |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lip and Oral Cavity Cancer, Head and Neck Cancer, Oropharyngeal Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, fluorouracil, ONYX-015 |
| Enrollment | 0 |
| Start date | Jul 1, 1999 |
| First posted | Apr 29, 2004 |
| Last update posted | Jul 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: